Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry

Abstract Background Uterine somatic choriocarcinoma is a rare, clinically aggressive malignant tumor. They frequently concur with other cancer. However, the molecular pathogenesis between somatic choriocarcinoma and the concurrent carcinoma has rarely been addressed to date. Case presentation We rep...

Full description

Bibliographic Details
Main Authors: Meiping Li, Lei Bao, Bo Lu, Wenshun Ge, Lifang Ren
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Diagnostic Pathology
Subjects:
Online Access:https://doi.org/10.1186/s13000-022-01262-z
_version_ 1798029940354973696
author Meiping Li
Lei Bao
Bo Lu
Wenshun Ge
Lifang Ren
author_facet Meiping Li
Lei Bao
Bo Lu
Wenshun Ge
Lifang Ren
author_sort Meiping Li
collection DOAJ
description Abstract Background Uterine somatic choriocarcinoma is a rare, clinically aggressive malignant tumor. They frequently concur with other cancer. However, the molecular pathogenesis between somatic choriocarcinoma and the concurrent carcinoma has rarely been addressed to date. Case presentation We report a 68-years old Chinese woman with a uterine choriocarcinoma arising from serous carcinoma. The patient underwent radical surgery including total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy and pelvic lymph node resection. She received 10 courses of post-operative chemotherapy. She died of disease 13 months after her surgery. Microscopically, the tumor showed a biphasic pattern of choriocarcinoma and serous carcinoma. The choriocarcinomatous component showed a combination of cytotrophoblast, intermediate trophoblast and syncytiotrophoblast with hemorrhage and necrosis. The component of serous carcinoma was characterized by solid sheets of small cells with marked nuclear atypia and occasional glandular and papillary formation. PD-L1 was exclusively expressed in the choriocarcinomatous component. Next-generation sequencing revealed that the genetic abnormalities were overlapping between the two components.
first_indexed 2024-04-11T19:33:10Z
format Article
id doaj.art-96de3ce868fc4456b72eb40b24521496
institution Directory Open Access Journal
issn 1746-1596
language English
last_indexed 2024-04-11T19:33:10Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Diagnostic Pathology
spelling doaj.art-96de3ce868fc4456b72eb40b245214962022-12-22T04:06:57ZengBMCDiagnostic Pathology1746-15962022-10-011711610.1186/s13000-022-01262-zUterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistryMeiping Li0Lei Bao1Bo Lu2Wenshun Ge3Lifang Ren4Department of Surgical Pathology, Shaoxing Maternity and Child Health Care HospitalDepartment of Surgical Pathology, Shaoxing Maternity and Child Health Care HospitalDepartment of Surgical Pathology, Shaoxing Maternity and Child Health Care HospitalDepartment of Surgical Pathology, Shaoxing Maternity and Child Health Care HospitalDepartment of Surgical Pathology, Shaoxing Maternity and Child Health Care HospitalAbstract Background Uterine somatic choriocarcinoma is a rare, clinically aggressive malignant tumor. They frequently concur with other cancer. However, the molecular pathogenesis between somatic choriocarcinoma and the concurrent carcinoma has rarely been addressed to date. Case presentation We report a 68-years old Chinese woman with a uterine choriocarcinoma arising from serous carcinoma. The patient underwent radical surgery including total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy and pelvic lymph node resection. She received 10 courses of post-operative chemotherapy. She died of disease 13 months after her surgery. Microscopically, the tumor showed a biphasic pattern of choriocarcinoma and serous carcinoma. The choriocarcinomatous component showed a combination of cytotrophoblast, intermediate trophoblast and syncytiotrophoblast with hemorrhage and necrosis. The component of serous carcinoma was characterized by solid sheets of small cells with marked nuclear atypia and occasional glandular and papillary formation. PD-L1 was exclusively expressed in the choriocarcinomatous component. Next-generation sequencing revealed that the genetic abnormalities were overlapping between the two components.https://doi.org/10.1186/s13000-022-01262-zChoriocarcinomaEndometriumSerous carcinomaPD-L1Next-generation sequencing
spellingShingle Meiping Li
Lei Bao
Bo Lu
Wenshun Ge
Lifang Ren
Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
Diagnostic Pathology
Choriocarcinoma
Endometrium
Serous carcinoma
PD-L1
Next-generation sequencing
title Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
title_full Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
title_fullStr Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
title_full_unstemmed Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
title_short Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
title_sort uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman an analysis of next generation sequencing and pd l1 immunochemistry
topic Choriocarcinoma
Endometrium
Serous carcinoma
PD-L1
Next-generation sequencing
url https://doi.org/10.1186/s13000-022-01262-z
work_keys_str_mv AT meipingli uterinechoriocarcinomaarisingfromserouscarcinomainapostmenopausalwomanananalysisofnextgenerationsequencingandpdl1immunochemistry
AT leibao uterinechoriocarcinomaarisingfromserouscarcinomainapostmenopausalwomanananalysisofnextgenerationsequencingandpdl1immunochemistry
AT bolu uterinechoriocarcinomaarisingfromserouscarcinomainapostmenopausalwomanananalysisofnextgenerationsequencingandpdl1immunochemistry
AT wenshunge uterinechoriocarcinomaarisingfromserouscarcinomainapostmenopausalwomanananalysisofnextgenerationsequencingandpdl1immunochemistry
AT lifangren uterinechoriocarcinomaarisingfromserouscarcinomainapostmenopausalwomanananalysisofnextgenerationsequencingandpdl1immunochemistry